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198 The Journal of Thoracic and CardioObjective: Airway complications are a recognized surgical complication and an
important source of morbidity after adult lung transplantation. Little is known about
these complications after pediatric lung transplantation.
Methods: Data of pediatric lung transplants performed between January 1990 and
December 2002 in a single pediatric institution were reviewed retrospectively.
Results: A total of 214 patients, with a mean age of 9.8  6.1 years (range 0.01-19.7
years), underwent 239 lung transplants: 231 bilateral and 8 single. Mean follow-up
was 3.4 years. Forty-two airway complications requiring interventions (stenosis 
36; dehiscence 4; malacia 2) developed in 30 recipients (complication rate: 9%
of 470 bronchial anastomoses at risk). There were airway complications in 29
bilateral lung transplants (13%) and 1 single lung transplant (13%). Mean time to
diagnosis was 51  27 days (median: 53, range 1-96 days), and diagnoses were
made in 90% of patients within the first 3 months after transplantation. Preoperative
Pseudomonas cepacia, postoperative fungal lung infection, and days on mechanical
ventilator were found to be significant risk factors on multivariate analysis (P 
.002, P .013 and P .003, respectively). Treatment included rigid bronchoscopic
dilatation in 17 patients, balloon dilatation in 13 patients, and stent placement in 12
patients. Other treatments consisted of debridement, fibrin glue application, chest
tube placement, and pneumonectomy followed by retransplantation. No patients
died as a direct result of airway complications. There was no significant difference
in the incidence of bronchiolitis obliterans or overall survival in comparison with
patients who did not have airway complications.
Conclusions: Airway complications are a significant cause of morbidity after pedi-
atric lung transplantation. The majority are successfully treated, and patient out-
comes are not adversely affected.
T he first human lung transplantation was reported by Hardy and colleagues1in 1963. For 2 decades after that, airway complications, mainly dehiscence,were the most frequent cause of early mortality and a major reason for the
failure of clinical lung transplantation.2 The development of improved anasto-
motic techniques resulted in the first clinically successful lung transplantation in
1983 and a subsequent decline in the frequency of airway complications.3-5
vascular Surgery ● January 2006
Choong et al Cardiothoracic Transplantation
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airway complications to be between 9% and 15% of the
anastomoses at risk, with a related mortality of 2% to
3%.5,6 Pediatric lung recipients are unique in several
ways in comparison with their adult counterparts in that
they are younger, smaller, and with bronchial cartilage
that has a higher compliance. In recognition of the scarce
data in the literature regarding airway complications after
pediatric lung transplantation, we reviewed our experi-
ence in this area in a single pediatric center.
Patients and Methods
Patients
Between January 1990 and December 2002, a total of 214 patients
underwent 239 isolated lung transplants at the St Louis Children’s
Hospital; 231 were bilateral sequential lung transplants (BLTs)
and 8 were single lung transplants (SLTs). Twenty-five of the
BLTs were retransplantations. Because the study was to evaluate
only bronchial anastomotic complications, this series excluded
the 10 heart-lung transplants performed in this hospital in which
none of the patients had any airway complications. The mean
follow-up was 3.4 years. The median age at the time of transplan-
tation in the study population was 11.2 years (range 0.1-19.7
years), with a mean age of 9.8  6.1 years. Analysis was per-
formed by a retrospective review of prospectively collected pedi-
atric data and medical records.
Operative Technique
The methods for standard donor lung harvest and implantation
have been described.7 The donor lungs are perfused with alpros-
tadil (prostaglandin E1), flushed with modified Euro-Collins solu-
tion, excised, and transported on ice to the recipient’s surgical
suite. BLT was performed through a bilateral anterolateral trans-
sternal (clamshell) thoracotomy incision through the fourth inter-
costal space. SLT was performed through an anterolateral thora-
cotomy extended across the sternum into the contralateral chest.
Cardiopulmonary bypass was used in all patients because the
airways in children are too small to safely accommodate the
double-lumen endotracheal tubes that are necessary for single-lung
ventilation. The donor bronchus was trimmed to within 2 cartilag-
inous rings of the take-off of the upper lobe bronchus on each side.
Early in our experience, 7 bronchial anastomoses in 5 patients (3
SLTs and 2 BLTs) were performed using a telescoping technique
with continuous absorbable running suture to the membranous
portion and interrupted mattress sutures to the cartilaginous por-
tion. All other subsequent bronchial anastomoses were performed
as an end-to-end anastomosis with continuous absorbable mono-
filament suture to the membranous portion and simple interrupted
absorbable sutures to the cartilaginous portion. Omentum was
Abbreviations and Acronyms
BLT bilateral lung transplant
SLT  single lung transplantinitially used in the beginning of our transplantation program to
The Journal of Thoraciwrap around 4 bronchial anastomoses in 2 patients who underwent
BLT. Omentum was substituted by pericardium and used to wrap
45 bronchial anastomoses in the subsequent 24 patients (3 SLTs
and 21 BLTs). Since 1993, peribronchial tissues have been used to
wrap around all the bronchial anastomoses; 5-0 monofilament
absorbable suture was used in children up to the age of 10 years,
and 4-0 suture was used in the older children. The arterial and
venous anastomoses were performed in an end-to-end fashion
using continuous suture of the same material. A Broviac catheter
(C. R. Bard, Inc, Murray Hill, NJ) was placed in all patients for
long-term vascular access.
Immunosuppression
“Triple drug” (cyclosporine [INN: ciclosporin], azathioprine, ste-
roids) immunosuppression is used. For the first year after trans-
plantation, the target trough cyclosporine blood level is 300 to 400
ng/mL, and for subsequent years it is 200 to 300 ng/mL. The initial
steroid dose is 0.5 mg/kg daily for prednisone. The steroid dose is
progressively tapered over time, but we do not believe it is appro-
priate to stop this drug entirely. An azathioprine dose of 1.5 mg/kg
daily is administered as long as the patient’s white blood cell count
exceeds 4000 cells/mm3.
Posttransplant Surveillance
An examination with a flexible fiberoptic bronchoscope was per-
formed within 24 hours of transplantation to assess airway anas-
tomosis. Thereafter, surveillance was performed by periodic
spirometry and flexible bronchoscopy with biopsies and bron-
choalveolar lavage. These were performed at 2 weeks, 1 month,
2 months, 3 months, and every 3 months thereafter, as well as
at any time that a change in clinical status occurred in which
rejection was a plausible explanation. A 3.3-mm flexible pedi-
atric bronchoscope was used in children younger than 1 year of
age. A 4.5- or 5-mm flexible bronchoscope was used for the older
children. Bronchoscopy was performed in the operating room
under laryngeal mask anesthesia for children aged less than 2 years
and as an outpatient procedure for children aged 2 years or older.
The technique of transbronchial biopsy performed in infants has
been described.8 When tissue sampling was inadequate, and a
change in clinical status persisted, open lung biopsy was per-
formed. Formal pulmonary function measurements were per-
formed at the same intervals as for bronchoscopy. Children aged
less than 5 years are generally not able to fully cooperate for
standard pulmonary function tests. They are therefore evaluated
with infant pulmonary function tests using standard techniques.9,10
Statistics
Descriptive statistics were used to describe the patients’ charac-
teristics and outcomes. Normally distributed continuous data are
expressed as means  SD throughout. Medians with ranges are
used when continuous data are not normally distributed. Categor-
ical data are expressed as counts and proportions. The chi-square
or Fisher exact test was used to analyze the categorical data.
Kaplan-Meier (product-limit) graphs were used to demonstrate
survival over time and freedom from bronchiolitis obliterans.
Survival and event-free survival comparisons between groups of
patients were completed using the Mantel-Haenszel log-rank test.
Logistic regression analysis was used to discriminate independent
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diatric lung transplantation. The development of airway compli-
cation was selected as the primary outcome. The likelihood ratio
method was used to determine hazard ratios, and the hazard ratio
was used to approximate the relative risk. All data analysis was
performed using SPSS (SPSS 11.0 for Windows; SPSS Inc, Chi-
cago, Ill).
Results
For the purpose of this review, an airway complication was
defined as a finding of stenosis, malacia, or dehiscence that
necessitated intervention such as dilatation, debridement, or
stent placement. Mucosal necrosis or slough detected by
bronchoscopy was not considered an airway complication
when satisfactory healing occurred without intervention. Of
470 bronchial anastomoses, 42 airway complications requir-
ing intervention developed in 30 recipients with an inci-
dence of 9% of the 470 anastomoses at risk. Thirty-six of
these complications were bronchial stenosis, 3 were partial
dehiscence, 1 was a complete dehiscence, and 2 were bron-
chomalacia. The age distributions of patients with and with-
out airway complications are shown in Figure 1. The inci-
dence of airway complications was 19% (10/53) in patients
aged less than 2 years and 14% (16/117) in older children
aged 11 to 18 years. There was no significant difference
when these groups were compared (P .39). The incidence
of airway complications was 17.6% (18/102) for transplants
performed between 1990 and 1996, and 10.7% (12/112)
(P  .145) for transplants performed between 1997 and
2002. The median time to diagnosis was 53 (1-96) days with
Figure 1. Age distribution of pa mean of 51  27 days. Ninety percent of these airway
200 The Journal of Thoracic and Cardiovascular Surgery ● Janucomplications were diagnosed within the first 3 months after
transplantation. Airway complications were detected inci-
dentally in 11 patients during surveillance bronchoscopy.
These patients were asymptomatic. Clinical presentations
that led to the diagnosis of airway complications in the other
patients were failure to wean from mechanical ventilation in
6 patents, worsening of pulmonary function tests in 6 pa-
tients, unexplained respiratory failure in 2 patients, wheez-
ing in 2 patients, stridor in 1 patient, retained secretions in
1 patient, and fever in 1 patient.
Risk Factors
Independent predictors for airway complications when ac-
counting for the other covariates are shown in Table 1.
Preoperative Pseudomonas cepacia, postoperative fungal
lung infection, and days on mechanical ventilator were
found to be significant factors on multivariate analysis
(P .002, P  .013 and P  .003, respectively). Pretrans-
plant diagnosis, age 2 years or less, preoperative steroid
usage, cytomegalovirus infection, ischemic time, and re-
transplantations were not significant risk factors. Early in
our lung transplant program, 7 bronchial anastomoses were
performed using a telescoped technique. Two bronchial
stenoses and 1 partial dehiscence occurred in 3 of these
patients with an incidence of 43%; the technique was aban-
doned after that.
Treatment
All bronchial stenoses were initially treated by dilatation. Up to
ts. AC, Airway complication.atien1995, the technique was to place a grasping forceps through
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forceps within it. After that, the stenosis was gradually dila-
tated using a rigid bronchoscope. The sizes of rigid broncho-
scopes used were dependent on the age and size of the child.
Since 1995, balloon dilatations performed through the rigid
bronchoscope were used instead of using the rigid bronchos-
copy itself to dilate. The balloon technique was thought to be
a simpler, safer, and less traumatic approach while at the same
time achieving similar dilatation results as that of rigid bron-
choscopy. The balloon diameter sizes were 8 mm for children
aged less than 1 year, 10 mm for children aged between 1 and
8 years, 12 mm for children aged between 8 and 12 years, and
14 mm for children aged 12 years or older. After the initial
dilatation, bronchoscopy was performed 3 weeks later. Dilata-
tion was repeated if the stenosis recurred. Up to 1995, a
silicone rubber stent (Silastic; Dow Corning Corp, Midland,
Mich) was inserted if the stenosis was severe and had narrowed
the orifice down to 50% or more of the baseline. The baseline
used for comparison was normal looking, healthy bronchus
proximal or distal to the anastomosis or the contralateral bron-
chial anastomosis. The technique has been described.11 Care is
taken to place these stents such that the upper lobe bronchi
remain patent and unobstructed by the stent. Since 1995, we
have used dilatation alone for the treatment of stenosis to avoid
the complications associated with stents such as mucus impac-
tion, granulation tissue formation, dislodgment, and migration.
Subsequent bronchoscopy was then arranged at various time
points ranging from 3 weeks to 3 months dependent on the
degree of residual stenosis and response to treatment.
Between 1990 and 1995, there were 12 bronchial steno-
ses that were treated by rigid bronchoscopic dilatation. The
median number of interventions was 2 (range 1-22), and the
mean was 4.2  6.2. Between 1995 and 2002, there were 9
bronchial stenoses that were treated with balloon dilatation.
The median number of balloon interventions was 5 (range
1-7), and the mean was 4.1  2.2. Silicone rubber stents
were placed in 12 bronchial anastomoses. These stents were
TABLE 1. Pretransplant diagnosis and risk factors for airw
Variable AC (n  30)
Pretransplant diagnosis
Cystic fibrosis (n  106) 11 (37%)
Pulmonary vascular disease (n  39) 5 (17%)
Pulmonary fibrosis (n  5) 1 (3%)
Bronchiolitis obliterans (n  9) 2 (7%)
Statistical analysis
Age (y) 9.6 6.9
Ischemic time (min) 249 68
Pseudomonas cepacia infection 3 (10%)
Postoperative fungal infection 8 (27%)
Days on ventilator 12 (1-254)
AC, Airway complication; CI, confidence interval; NA, not available.left in place for a minimum of 6 months. Four of the 12
The Journal of Thoracistents placed caused complications that required interven-
tions. These complications included dislodgment, obstruc-
tion by mucus impaction, and granulation tissue formation.
All silicone rubber stents were ultimately removed with
resolution of the stenosis. One patient with Aspergillus
infection of the airway had a complete dehiscence of the
right bronchial anastomosis 1 day after surgery and under-
went reoperative repair. The repaired anastomosis com-
pletely dehisced again, and a pneumonectomy was per-
formed 8 days after the repair. Retransplantation was
performed 25 days after the pneumonectomy. Partial dehis-
cence of the anastomoses developed in 3 other patients, 1 of
whom had a bronchopleural fistula and pneumothorax re-
quiring chest tube insertion and drainage of the pneumotho-
rax. One patient with partial dehiscence had bronchial ste-
nosis that necessitated dilatation, and another patient had
formation of granulation tissue that necessitated debride-
ment. The remaining patient with partial dehiscence was
successfully treated with topical fibrin glue sealant. Two
patients had bronchomalacia and were treated with wire
mesh metal expandable stents. Metal stents were used for
these patients because they had bronchiolitis obliterans
and had a limited long-term survival; thus it was reason-
able to use the metallic stents despite the disadvantages
of restricting the growth of the bronchus and not being
able to remove it.
Late Complications
Fifteen of the 30 patients who had an airway complication
had bronchiolitis obliterans (50%). This finding was not
significantly different in comparison with patients who did
not have airway complications (Figure 2). The 1-, 3-, and
5-year Kaplan-Meier freedom from bronchiolitis obliterans
for patients with and without airway complications are
73.2%, 49.6%, 36.2%, and 81.1%, 57.2%, and 47.6%, re-
spectively (log rank 1.88, P  .17).
No patients died as a direct result of airway complica-
omplications
Non-AC (n  184) P value Relative risk (CI)
.68 NA
95 (52%) NA
34 (18%) NA
4 (2%) NA
7 (4%) NA
9.9 6.1 .961 NA
247  93 .908 NA
1 (0.5%) .002 29.36 (2.84-303.26)
23 (13%) .01 3.81 (1.39-10.49)
4 (1-128) .003 1.02 (1.01-1.04)ay ctions. There was no significant difference in the overall
c and Cardiovascular Surgery ● Volume 131, Number 1 201
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plications did not develop (Figure 3).
Discussion
The bronchial anastomosis in lung transplantation is unique
in that there is no direct blood supply to the bronchus to
promote healing. Circulation to this area depends on retro-
grade filling of the bronchial vessels from the pulmonary
arterial circulation through the communications with pul-
monary capillaries and other precapillary anastomoses.
Maintenance of blood flow through these tenuous channels
is critical for the healing of the airway anastomosis until
systemic neovascularization of the bronchial circulation
through collaterals occurs, which may take 3 to 4 weeks.12
Direct bronchial revascularization has been proposed by
some centers in an effort to lower the incidence of airway
complications.13 The disadvantages are that it prolongs the
operation, increases the risk of bleeding, is technically dif-
ficult, and may be more so in the pediatric population with
their smaller arterial sizes. For these reasons, we have not
adopted the technique of direct revascularization. Indirect
revascularization using omentopexy was at one time stan-
dard practice.14 There is experimental evidence of new
vessel ingrowth to the area of bronchial anastomosis with
omentopexy as early as 4 days after transplant.15 The use of
viable peribronchial tissue to wrap around the bronchial
anastomosis is now the standard practice and has provided
results similar to omentopexy and is less complicated.5
Technical factors such as the shortening of the donor
bronchus to within 1 to 2 cartilaginous rings of the take-off
of the upper lobe bronchus have also been implicated as
important factors that impact the healing of bronchial anas-
tomosis.16 These factors have been shown to minimize the
degree of ischemia at the level of the anastomosis. Tele-
scoping the anastomosis by intussuscepting the donor bron-
Figure 2. Kaplan-Meier freedom from bronchiolitis obliterans.
BOS, Bronchiolitis obliterans.chus into the recipient has been adopted by some centers
202 The Journal of Thoracic and Cardiovascular Surgery ● Januwith good results.17 It is usual to have some telescoping
because the donor bronchus is frequently smaller than the
recipient. In our series, telescoping using mattress sutures
was performed during the initial phase of the program and
was associated with a high incidence of complications in
which 3 of 7 of the anastomoses became stenotic. Others
have had a similar experience.18 The telescoped technique
was used during the early part of our pediatric lung trans-
plantation program, and it may be that the difference in
results simply represents the effect of the learning curve. It
may also be possible that the smaller airway diameter of
pediatric patients may be more prone to stenosis with the
telescoped technique. Because the technique was aban-
doned early, it is unknown whether the prevalence of anas-
tomotic narrowing would decrease if we had continued to
use this technique. The small number of telescoped anasto-
moses in comparison with the end-to-end technique is also
a limitation in comparing the difference in the prevalence of
anastomotic narrowing between the 2 techniques.
As our transplant program took on smaller children, we
were concerned about potential airway complications in
infants. We were concerned that any narrowing induced by
swelling or inflammation would be detrimental to the small
infantile airways and that the small diameter of the airway
may be a risk factor for the development of stenosis. In our
experience, the incidence of airway complication was not
significantly different between the children aged less than 2
and older children aged between 11 and 18 years. Eleven of
the 30 recipients (37%) who had airway complications were
asymptomatic, and the airway complications were detected
incidentally on surveillance bronchoscopy. These findings
emphasize the importance of performing routine surveil-
lance bronchoscopy in this population.
Various treatment modalities have been reported for the
Figure 3. Kaplan-Meier overall survival.management of airway complications after lung transplan-
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stents, laser therapy, and resection of stenotic bronchus with
reanastomosis.11,19-23 Our preferred choice in the treatment
of bronchial stenosis is balloon dilatation, which has the
advantages of being less traumatic, easier to apply, and
more accurate dilatation of the stenotic segment in compar-
ison with rigid bronchoscopic dilatation. This has been
successful in our experience as well as that of others.5,24 As
opposed to vascular structures, there is no intraluminal
pressure to help maintain airway patency during healing.
During inspiration, the intraluminal pressure of airway
anastomosis is generally higher than the extraluminal in-
trathoracic pleural pressure, and this may contribute to the
maintenance of airway patency when a stricture is not
particularly severe. Intraluminal silicone rubber stents were
believed to be useful when the stenosis was severe. We have
previously placed silicone rubber stents in severe strictures;
however, mucus plugging, dislodgement of the stent, and
incitement of granulation tissue growth complicate their
use. We now perform periodic balloon dilatation instead of
stenting and have found that this effectively remodels the
airway stenosis to a satisfactory diameter without the stents.
Expandable metal stents have been reported to be a useful
treatment modality for airway complications.25,26 These
stents, however, cannot be used unless the airway is com-
pletely epithelized and in general cannot be removed. They
can also incite granulation tissue that may grow through the
wire mesh producing obstruction. The removal of the ste-
notic segment either as a sleeve resection of the airway or
lobectomy has been performed with excellent results.22
However, the reported series included all adult patients and
was a treatment option reserved for patients in whom con-
ventional treatment failed or in whom the stenosis extended
down into the more distal airway. Retransplantation is a
final option but carries with it the unpredictable waiting
time. Retransplantation is associated with higher morbidi-
ties and mortalities.27,28 When the stenosis extends down
into the lobar orifices, there may not be a plausible alterna-
tive treatment.
In conclusion, the incidence of airway complications in
our pediatric series was similar to that reported in the adult
lung transplant population. Airway complications were a
significant cause of morbidity after pediatric lung transplan-
tation. The majority was however successfully treated, and
patient outcomes were not adversely affected.
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